VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 140 filers reported holding VIKING THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $817,021 | -31.3% | 73,805 | +0.6% | 0.01% | -30.0% |
Q2 2023 | $1,189,603 | +38.1% | 73,387 | +41.9% | 0.01% | +25.0% |
Q1 2023 | $861,105 | +76.0% | 51,718 | -0.6% | 0.01% | +100.0% |
Q4 2022 | $489,204 | +102.2% | 52,043 | -35.4% | 0.00% | +33.3% |
Q1 2022 | $242,000 | -41.8% | 80,540 | -11.0% | 0.00% | -40.0% |
Q4 2021 | $416,000 | -30.9% | 90,539 | -5.5% | 0.01% | -16.7% |
Q3 2021 | $602,000 | -2.3% | 95,835 | -6.8% | 0.01% | +20.0% |
Q2 2021 | $616,000 | -26.2% | 102,865 | -22.1% | 0.01% | -37.5% |
Q1 2021 | $835,000 | +12.8% | 131,978 | +0.4% | 0.01% | 0.0% |
Q4 2020 | $740,000 | +37.0% | 131,509 | +41.7% | 0.01% | 0.0% |
Q3 2020 | $540,000 | -24.4% | 92,790 | -6.3% | 0.01% | -20.0% |
Q2 2020 | $714,000 | +16.1% | 99,027 | -24.6% | 0.01% | 0.0% |
Q1 2020 | $615,000 | -47.7% | 131,378 | -10.4% | 0.01% | +11.1% |
Q4 2019 | $1,177,000 | +18.8% | 146,700 | +1.9% | 0.01% | +12.5% |
Q3 2019 | $991,000 | -20.8% | 144,019 | -4.5% | 0.01% | -11.1% |
Q2 2019 | $1,252,000 | -27.0% | 150,810 | -12.6% | 0.01% | -25.0% |
Q1 2019 | $1,716,000 | +35.9% | 172,603 | +4.5% | 0.01% | +20.0% |
Q4 2018 | $1,263,000 | – | 165,145 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |